Discontinuation report IRINOTECAN HYDROCHLORIDE INJECTION
Report ID | 159004 |
Drug Identification Number | 02412187 |
Brand name | IRINOTECAN HYDROCHLORIDE INJECTION |
Common or Proper name | IRINOTECAN HYDROCHLORIDE INJECTION |
Company Name | TELIP, LLC, A SUBSIDIARY OF TELIGENT, INC. |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | IRINOTECAN HYDROCHLORIDE |
Strength(s) | 20MG |
Dosage form(s) | SOLUTION SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 5ML |
ATC code | L01XX |
ATC description | OTHER ANTINEOPLASTIC AGENTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2022-04-19 |
Remaining supply date | 2022-04-19 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 105 LINCOLN AVE BUENA, NEW JERSEY UNITED STATES 08310 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2022-04-20 | English | Compare |
v4 | 2022-04-19 | French | Compare |
v3 | 2022-04-19 | French | Compare |
v2 | 2022-04-19 | English | Compare |
v1 | 2022-04-19 | English | Compare |
Showing 1 to 5 of 5